These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 2354446

  • 21. Outcome of photodynamic therapy using NPe6 for bronchogenic carcinomas in central airways >1.0 cm in diameter.
    Usuda J, Ichinose S, Ishizumi T, Hayashi H, Ohtani K, Maehara S, Ono S, Honda H, Kajiwara N, Uchida O, Tsutsui H, Ohira T, Kato H, Ikeda N.
    Clin Cancer Res; 2010 Apr 01; 16(7):2198-204. PubMed ID: 20332318
    [Abstract] [Full Text] [Related]

  • 22. Expression of vascular endothelial growth factor by photodynamic therapy with mono-L-aspartyl chlorin e6 (NPe6) in oral squamous cell carcinoma.
    Nakagawa H, Matsumiya T, Sakaki H, Imaizumi T, Kubota K, Kusumi A, Kobayashi W, Kimura H.
    Oral Oncol; 2007 Jul 01; 43(6):544-50. PubMed ID: 17257889
    [Abstract] [Full Text] [Related]

  • 23. CHOP activation by photodynamic therapy increases treatment induced photosensitization.
    Wong S, Luna M, Ferrario A, Gomer CJ.
    Lasers Surg Med; 2004 Jul 01; 35(5):336-41. PubMed ID: 15611953
    [Abstract] [Full Text] [Related]

  • 24. Skin necrosis due to photodynamic action of benzoporphyrin depends on circulating rather than tissue drug levels: implications for control of photodynamic therapy.
    Lin GC, Tsoukas ML, Lee MS, González S, Vibhagool C, Anderson RR, Kollias N.
    Photochem Photobiol; 1998 Oct 01; 68(4):575-83. PubMed ID: 9796441
    [Abstract] [Full Text] [Related]

  • 25. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
    Kirveliene V, Grazeliene G, Dabkeviciene D, Micke I, Kirvelis D, Juodka B, Didziapetriene J.
    Cancer Chemother Pharmacol; 2006 Jan 01; 57(1):65-72. PubMed ID: 16001168
    [Abstract] [Full Text] [Related]

  • 26. Phase II clinical study of photodynamic therapy using mono-L-aspartyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lung.
    Kato H, Furukawa K, Sato M, Okunaka T, Kusunoki Y, Kawahara M, Fukuoka M, Miyazawa T, Yana T, Matsui K, Shiraishi T, Horinouchi H.
    Lung Cancer; 2003 Oct 01; 42(1):103-11. PubMed ID: 14512194
    [Abstract] [Full Text] [Related]

  • 27. Photodynamic therapy with a diode laser for implanted fibrosarcoma in mice employing mono-L-aspartyl chlorin E6.
    Katsumi TA, Aizawa K, Kuroiwa Y, Saito K, Kurata Y, Ii Y, Okunaka T, Konaka C, Kato H.
    Photochem Photobiol; 1996 Oct 01; 64(4):671-5. PubMed ID: 8863472
    [Abstract] [Full Text] [Related]

  • 28. Potentiation of photodynamic therapy antitumor activity in mice by nitric oxide synthase inhibition is fluence rate dependent.
    Henderson BW, Sitnik-Busch TM, Vaughan LA.
    Photochem Photobiol; 1999 Jul 01; 70(1):64-71. PubMed ID: 10420844
    [Abstract] [Full Text] [Related]

  • 29. Structure-activity relationships of mono-substituted trisulfonated porphyrazines for the photodynamic therapy (PDT) of cancer.
    Cauchon N, Ali H, Hasséssian HM, van Lier JE.
    Photochem Photobiol Sci; 2010 Mar 01; 9(3):331-41. PubMed ID: 20221459
    [Abstract] [Full Text] [Related]

  • 30. Photodynamic therapy for lung cancers based on novel photodynamic diagnosis using talaporfin sodium (NPe6) and autofluorescence bronchoscopy.
    Usuda J, Tsutsui H, Honda H, Ichinose S, Ishizumi T, Hirata T, Inoue T, Ohtani K, Maehara S, Imai K, Tsunoda Y, Kubota M, Ikeda N, Furukawa K, Okunaka T, Kato H.
    Lung Cancer; 2007 Dec 01; 58(3):317-23. PubMed ID: 17698240
    [Abstract] [Full Text] [Related]

  • 31. Morphologic evaluation of the antitumor activity of photodynamic therapy (PDT) using mono-L-aspartyl chlorin e6 (NPe6) against uterine cervical carcinoma cell lines.
    Nakamura H, Suzuki Y, Takeichi M, Saito T, Takayama M, Aizawa K.
    Int J Gynecol Cancer; 2002 Dec 01; 12(2):177-86. PubMed ID: 11975677
    [Abstract] [Full Text] [Related]

  • 32. Tolyporphin: a natural product from cyanobacteria with potent photosensitizing activity against tumor cells in vitro and in vivo.
    Morlière P, Mazière JC, Santus R, Smith CD, Prinsep MR, Stobbe CC, Fenning MC, Golberg JL, Chapman JD.
    Cancer Res; 1998 Aug 15; 58(16):3571-8. PubMed ID: 9721863
    [Abstract] [Full Text] [Related]

  • 33. Tissue distribution and pharmacokinetics of an ATWLPPR-conjugated chlorin-type photosensitizer targeting neuropilin-1 in glioma-bearing nude mice.
    Thomas N, Tirand L, Chatelut E, Plénat F, Frochot C, Dodeller M, Guillemin F, Barberi-Heyob M.
    Photochem Photobiol Sci; 2008 Apr 15; 7(4):433-41. PubMed ID: 18385885
    [Abstract] [Full Text] [Related]

  • 34. Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors.
    Ferrario A, Fisher AM, Rucker N, Gomer CJ.
    Cancer Res; 2005 Oct 15; 65(20):9473-8. PubMed ID: 16230411
    [Abstract] [Full Text] [Related]

  • 35. Tailor-made approach to photodynamic therapy in the treatment of cancer based on Bcl-2 photodamage.
    Usuda J, Hirata T, Ichinose S, Ishizumi T, Inoue T, Ohtani K, Maehara S, Yamada M, Tsutsui H, Okunaka T, Kato H, Ikeda N.
    Int J Oncol; 2008 Oct 15; 33(4):689-96. PubMed ID: 18813781
    [Abstract] [Full Text] [Related]

  • 36. Angiographic and histologic effects of fundus photodynamic therapy with a hydrophilic sensitizer (mono-L-aspartyl chlorin e6).
    Mori K, Yoneya S, Ohta M, Sano A, Anzai K, Peyman GA, Moshfeghi DM.
    Ophthalmology; 1999 Jul 15; 106(7):1384-91. PubMed ID: 10406627
    [Abstract] [Full Text] [Related]

  • 37. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
    Bellnier DA, Gollnick SO, Camacho SH, Greco WR, Cheney RT.
    Cancer Res; 2003 Nov 15; 63(22):7584-90. PubMed ID: 14633671
    [Abstract] [Full Text] [Related]

  • 38. Skin fluorescence following photodynamic therapy with NPe6 photosensitizer.
    Ohtani K, Usuda J, Ogawa E, Maehara S, Imai K, Kudo Y, Ono S, Shigefuku S, Eriguchi D, Inoue T, Maeda J, Yoshida K, Hagiwara M, Kakihana M, Kajiwara N, Ohira T, Arai T, Ikeda N.
    Photodiagnosis Photodyn Ther; 2017 Dec 15; 20():210-214. PubMed ID: 28988135
    [Abstract] [Full Text] [Related]

  • 39. [Dynamics of photosensitizer in the cell].
    Aizawa K, Kuroiwa Y, Tsuchida T, Xiahedin I, Shibuya H, Saito K.
    Gan To Kagaku Ryoho; 1996 Jan 15; 23(1):22-6. PubMed ID: 8546464
    [Abstract] [Full Text] [Related]

  • 40. Foscan-based photodynamic treatment in vivo: correlation between efficacy and Foscan accumulation in tumor, plasma and leukocytes.
    Maugain E, Sasnouski S, Zorin V, Merlin JL, Guillemin F, Bezdetnaya L.
    Oncol Rep; 2004 Sep 15; 12(3):639-45. PubMed ID: 15289849
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.